"We are very pleased to see our successful trial production at the new glucose complex. The official launch of its production should further satisfy strong demand of glucose products, especially for pharmaceutical grade glucose products," said Chairman and CEO, Mr. Qingtai Liu, "We will be shifting more excess cornstarch to be utilized internally to the new glucose complex, which will strengthen our glucose business and improve our profitability. We will also continue to manufacture innovative products and diversify our product lines to meet market demand to pursue higher profit margin and minimize our operating risks."
Shengtai Pharmaceutical, Inc. will conduct a conference call at 9:00 a.m. Eastern Time on Friday, May 16, 2008 to discuss the third quarter results of fiscal year 2008.
To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 800-688-0796. International callers should dial 617-614-4070. When prompted by the operator, mention Conference Passcode 502 870 72.
If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Friday, May 16 at 11:00 a.m. Eastern Time. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888, and enter the passcode 924 807 90.
About Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary
Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese
operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a
leading manufacturer and supplier of glucose products, which include
pharmaceutical grade glucose used for medical purposes, and glucose and
cornstarch products for the food and beverage industry and for industrial
|SOURCE Shengtai Pharmaceutical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved